Collaborative prescribing: A qualitative exploration of a role for pharmacists in mental health

Research in Social and Administrative Pharmacy

Volumn 8, Issue 3, 2012, Pages 179-192

  Wheeler, Amanda ^a,b   Crump, Keith ^b,c   Lee, Monica ^b   Li, Leigh ^b   Patel, Ashna ^b   Yang, Rachel ^b   Zhao, Jenny ^b   Jensen, Maree ^b  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c Procare ^*  (New Zealand)

Author keywords

Collaborative prescribing; Mental health; Nonmedical prescribing; Pharmacy services

Indexed keywords

ARTICLE; ATTITUDE TO HEALTH; AWARENESS; CONSUMER; COOPERATION; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; INTERDISCIPLINARY COMMUNICATION; INTERVIEW; MALE; MENTAL HEALTH SERVICE; NEW ZEALAND; NURSE PRACTITIONER; PATIENT CARE; PERCEPTION; PHARMACIST; PHARMACY; PHYSICIAN; PRESCRIPTION; PROFESSIONAL STANDARD; PSYCHOLOGICAL ASPECT; PUBLIC OPINION; QUALITATIVE RESEARCH; RECOGNITION;

ATTITUDE OF HEALTH PERSONNEL; AWARENESS; COMMUNITY MENTAL HEALTH SERVICES; COMMUNITY PHARMACY SERVICES; CONSUMER SATISFACTION; COOPERATIVE BEHAVIOR; DRUG PRESCRIPTIONS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERDISCIPLINARY COMMUNICATION; INTERVIEWS AS TOPIC; MALE; NEW ZEALAND; NURSE PRACTITIONERS; PATIENT CARE TEAM; PERCEPTION; PHARMACISTS; PHYSICIANS; PROFESSIONAL ROLE; PUBLIC OPINION; QUALITATIVE RESEARCH; RECOGNITION (PSYCHOLOGY);

EID: 84860833361     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2011.04.003     Document Type: Article

References (65)

1. New Zealand Ministry of Health. Medicines New Zealand 2007. Available at: Accessed 19.01.09: ISBN 978-0-478-31255-3. http://www.moh.govt.nz/moh.nsf/indexmh/medicines-nz.
2. Pharmaceutical Society of New Zealand. Focus on the future: ten year vision for pharmacists in New Zealand: 2004-2014; 2004. Available at: Accessed 21.12.10. http://psnz.org.nz/public/home/documents/10_yea_plan.pdf.
3. United Kingdom Department of Health. Pharmacy in England: building on strengths-delivering the future; 2008. Available at: Accessed 19.01.09: ISBN 9780101734127. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_083815.
4. United States Department of Health and Human Services. Pharmacy affairs and 340B drug pricing program; 2008. Available at: Accessed 19.01.09. http://www.hrsa.gov/opa/introduction.htm.
5. Gilbert L. Pharmacy's attempts to extend its roles: case study in South Africa. Soc Sci Med 1998, 47:153-164. 10.1016/S0277-9536(98)00022-7.
6. Wheeler A., Hale A., Jensen M., Coombes I., Stokes J., Stowasser D., Nissen L. Pharmacist prescribing-taking steps toward the future. J Prim Health Care 2010, 2:72-73.
7. Abramowitz P.W. The evolution and metamorphosis of the pharmacy practice model. Am J Health Syst Pharm 2009, 66:1437-1446. 10.2146/ajhp090286.
8. Bissell P., Traulsen J.M. Sociology and Pharmacy Practice 2005, Pharmaceutical Press, London, UK. 1st ed.
9. Nissen L. Prescribing rights for pharmacists in Australia-are we getting any closer?. Pharmacist 2008, 27:624-629.
10. Hepler C.D. A dream deferred. Am J Health Syst Pharm 2010, 67:1319-1325.
11. District Health Boards New Zealand. DHBNZ Pharmacy Advisory Group. New Zealand National Pharmacist Services Framework: Version 1; 2007. Available at: Accessed 21.12.09. http://www.dhbnz.org.nz/Site/SIG/NPSF/NPSF-Framework.aspx.
12. Pharmacy Council of New Zealand. Medicines management. Definition, levels, competence framework [PDF]; 2006. Available at: Accessed 21.12.09. http://www.pharmacycouncil.org.nz/cms_show_download.php?id=44.
13. Pharmacy Council of New Zealand. Feedback on the consultation on the proposed advanced scope of practice and qualifications for pharmacists; 2007. Available at: Accessed 22.09.09. http://www.pharmacycouncil.org.nz/cms_show_download.php?id=15.
14. Pharmacy Council of New Zealand. Collaborative Pharmacy Practice-Pharmacist Prescribers: Report of Key Stakeholders Meeting 6 November 2009; 2009. Available at: Accessed 08.04.10. http://www.pharmacycouncil.org.nz/cms_show_download.php?id=128.
15. Pharmacy Council of New Zealand. Pharmacist Prescriber Scope of Practice-Consultation Outcome Report; 2010. Available at: Accessed 23.12.10. http://www.pharmacycouncil.org.nz/whats_new.
16. The World Health Report 2001: Mental Health: New Understanding, New Hope 2001, World Health Organisation (WHO), WHO, Geneva, Switzerland.
17. World Health Organization. The global burden of disease: 2004 update; 2008. Available at: Accessed 09.03.10: ISBN 978 92 4 156371 0. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf.
18. Stahl S.M. Stahl's Essential Psychopharmacology: Neurioscientific Basis and Practical Applications 2008, Cambridge University Press, New York. 3rd ed.
19. Keks N.A., Altson K., Hope J., et al. Use of antipsychosis and adjunctive medications by an inner urban community psychiatric service. Aust N Z J Psychiatry 1999, 33:896-901.
20. Owen R.R., Feng W., Thrush C.R., Hudson T.J., Austen M.A. Variations in prescribing practices for novel antipsychotic medications among Veterans Affairs hospitals. Psychiatr Serv 2001, 52:1523-1525.
21. Owen R.R., Thrush C.R., Kirchner J.E., Fischer E.P., Booth B.M. Performance measurement for schizophrenia: adherence to guidelines for antipsychotic dose. Int J Qual Health Care 2000, 12:475-482.
22. Mort J.R., Aparasu R.R. Prescribing of psychotropics in the elderly: why is it so often inappropriate?. CNS Drugs 2002, 16:99-109.
23. Leslie D.L., Rosenheck R.A. Benchmarking the quality of schizophrenia pharmacotherapy: a comparison of the Department of Veterans Affairs and the private sector. J Ment Health Policy Econ 2003, 6:113-121.
24. Meagher D., Moran M. Sub-optimal prescribing in an adult community mental health service: prevalence and determinants. Psychiatr Bull 2003, 27:266-270.
25. Harrington M., Lelliott P., Paton C., Konsolaki M., Sensky T., Okocha C. Variation between services in polypharmacy and combined high dose of antipsychotic drugs prescribed for in-patients. Psychiatr Bull 2002, 26:418-420.
26. Paton C., Lelliott P., Harrington M., Okocha C., Sensky T., Duffett R. Patterns of antipsychotic and anticholinergic prescribing for hospital inpatients. J Psychopharmacol 2003, 17:223-229.
27. Taylor D., Mir S., Kerwin R. Prescribing in schizophrenia. Evaluating the effect of introducing a new treatment protocol. Psychiatr Bull 2000, 24:106-108.
28. Adams J., Scott J. Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand 2000, 101:119-124.
29. Cramer J.A., Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv 1998, 49:196-201.
30. Gray R., Wykes T., Gournay K. From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication. J Psychiatr Ment Health Nurs 2002, 9:277-284.
31. Bell J.S., Rosen A., Aslani P., Whitehead P., Chen T.F. Developing the role of pharmacists as members of community mental health teams: Perspectives of pharmacists and mental health professionals. Res Soc Admin Pharm 2007, 3:392-409.
32. Finley P.R., Crismon M.L., Rush A.J. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy 2003, 23:1634-1644.
33. Gable K.N., Stunson M.J. Clinical pharmacist interventions on an assertive community treatment team. Community Ment Health J 2010, 46:351-355.
34. Ellenor G.L., Dishman B.R. Pharmaceutical care role model in psychiatry-pharmacist prescribing. Hosp Pharm 1995, 30:371-373.
35. Emmerton L., Marriott J., Bessell T., Nissen L., Dean L. Pharmacists and prescribing rights: review of international developments. J Pharm Pharm Sci 2005, 8:217-225.
36. Finley P.R., Rens H.R., Pont J.T., et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy 2003, 23:1175-1185.
37. McCann T.V., Clark E. Attitudes of patients towards mental health nurse prescribing of antipsychotic agents. Int J Pharm Pract 2008, 14:115-121.
38. Rana T., Bradley E., Nolan P. Survey of psychiatrists' views of nurse prescribing. J Psychiatr Ment Health Nurs 2009, 16:257-262.
39. Harrison A. Mental health service users' views of nurse prescribing. Nurse Prescribing 2003, 1:78-85.
40. McCann T.V., Baker H. Community mental health nurses and authority to prescribe medications: the way forward?. J Psychiatr Ment Health Nurs 2002, 9:175-182.
41. Wand T., Fisher J. The mental health nurse practitioner in the emergency department: an Australian experience. Int J Ment Health Nurs 2006, 15:201-208.
42. Smith F. Research Methods in Pharmacy Practice 2002, Pharmaceutical Press, London.
43. Kairuz T., Crump K., O'Brien A. An overview of qualitative research. Pharm J 2007, 277:312-314.
44. Kairuz T., Crump K., O'Brien A. Tools for data collection and analysis. Pharm J 2007, 278:371-377.
45. Krefting l Rigor in qualitative research: the assessment of trustworthiness. Am J Occup Ther 1991, 45:214-222.
46. Coombes I., Mitchell C., Stowasser D. Safe medication practice tutorials: a practical approach to preparing prescribers. Clin Teach 2007, 4:128-134.
47. Weeks G., Marriott J. Collaborative prescribing: view of SHPA pharmacist members. J Pharm Pract Res 2008, 38:271-275.
48. Shah B., Chewning B. Conceptualizing and measuring pharmacist-patient communication: a review of published studies. Res Soc Admin Pharm 2006, 2:153-185.
49. Stoudemire A., Thompson J.L. Medication noncompliance: systematic approaches to evaluation and intervention. Gen Hosp Psychiatry 1983, 5:233-239.
50. Perkins O. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 2002, 63:1121-1128.
51. Janis I.L. The role of social support in adherence to stressful decisions. Am Psychol 1983, 38:143-160.
52. Schwartzberg J.G., Cowett A., VanGeest J., Wolf M.S. Communication techniques for patients with low health literacy: a survey of physicians, nurses, and pharmacists. Am J Health Behav 2007, (31 suppl 1):S96-S104.
53. Dyck A., Deschamps M., Taylor J. Pharmacists' discussions of medication side effects: a descriptive study. Patient Educ Couns 2005, 56:21-27.
54. Mesquita A.R., Lyra D.P., Brito G.C., Balisa-Rocha B.J., Aguiar P.M., de Almeida Neto A.C. Developing communication skills in pharmacy: a systematic review of the use of simulated patient methods. Patient Educ Couns 2010, 78:143-148.
55. Zweber A. Cultural competence in pharmacy practice. Am J Pharm Educ 2002, 66:172-176.
56. Pharmacy Council of New Zealand. Cultural competence standards; 2008. Available at: Accessed 12.01.10. http://www.pharmacycouncil.org.nz/cms_show_download.php,id=57.
57. Baqir W., Smith J. Why pharmacist prescribing appears to be floundering. Br J Clin Pharm 2010, 2:150-151.
58. Baqir W., Clemerson J., Smith J. Evaluating pharmacist prescribing across the north east of England. Br J Clin Pharm 2010, 2:147-149.
59. Latter S, Blenkinsopp A, Chapman S, et al. The evaluation of nurse and pharmacist independent prescribing (ENPIP) study 2008-2009; 2009. Available at: Accessed 29.11.10. http://www.npc.co.uk/events/5thnon_medpresconf/presentations.
60. Hale A., Coombes I., Stowasser D., Nissen L. Evaluation of non-medical prescribing. Aust Health Rev 2011, 35:36.
61. Feetam C., Newton G. Pharmacist prescribing in mental health. Hosp Pharm 2004, 11:76-77.
62. Lincoln Y.S., Guba G.E. Naturalistic Inquiry 1985, Sage Publications, Newbury Park, CA.
63. Walker R.A., Martin S. Demographic profile for Waitemata DHB: An analysis of the 2006 Census 2007, Waitemata District Health Board, Auckland, New Zealand.
64. Te Rau Hinengaro: The New Zealand Mental Health Survey 2006, Ministry of Health, Wellington, New Zealand. M. Oakley-Browne, J. Wells, K. Scott (Eds.).
65. Hauora: Maori Standards of Health IV. A Study of the Years 2000-2005 2007, Te Ropu Rangahau Hauora a Eru Pomare, Wellington, New Zealand. B. Robson, R. Harris (Eds.).